According to , the Next Generation Immunology Drug Market is on a robust growth trajectory, with its size projected to reach 83.84 USD by 2035. The market share will be increasingly influenced by innovative treatment options and growing patient populations suffering from autoimmune diseases. Currently valued at 41.71 USD in 2024, the market is set to expand significantly as investments in...